In addition, another study from 2015 identified mTOR as the most relevant synthetic lethal mediator that contributes to ponatinib intrinsic sensitivity in a panel of FGFR1-amplified NSCLC cell lines. This evidence concerns the gene FGFR1 and non-small cell lung carcinoma.